Clinical Trials
3 trialsNCT04438382 2026-06-02
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT07619898 2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2 Not yet recruiting
NCT05034536 2026-05-18
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
Massachusetts General Hospital
Phase 2 Active not recruiting